Publications by authors named "Michael Lincoff"

Claim this Profile
C
Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes.
Phil McEwan, Martin Bøg, Mads Faurby, Volker Foos, Ildiko Lingvay, A Michael Lincoff

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial: Interleukin-6 Inhibition and Atherosclerotic Event Rate Reduction.
Paul M Ridker, Florian M M Baeres, Anders Hveplund, Mads M D Engelmann, G Kees Hovingh, A Michael Lincoff

JAMA Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
Stephen J Nicholls, Imre Pavo, Deepak L Bhatt, John B Buse, Stefano Del Prato, A Michael Lincoff

N Engl J Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.
Stephen J Nicholls, Donna H Ryan, John Deanfield, Daniel Ferreira, Chim C Lang, A Michael Lincoff

JAMA Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid: Clinical Insights From CLEAR Outcomes.
Kausik K Ray, Stephen J Nicholls, A Michael Lincoff, Na Li, Heather A Powell

JACC Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
John Deanfield, A Michael Lincoff, Steven E Kahn, Scott S Emerson, Ildiko Lingvay

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial.
Venu Menon, LeAnne Bloedon, Na Li, A Michael Lincoff, Stephen J Nicholls

J Clin Lipidol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial.
Thiago Gagliano-Jucá, Karol M Pencina, Yili V Shang, Thomas G Travison, A Michael Lincoff

Am Heart J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries.
Amgad Mentias, Neil Keshvani, Milind Y Desai, Samir R Kapadia, Khaled M Ziada, A Michael Lincoff

Circ Cardiovasc Qual Outcomes· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction.
Barry A Borlaug, Cecilie Holse, Mette Holme Jung, A Michael Lincoff, Sharon L Mulvagh

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a).
Leslie Cho, Stephen J Nicholls, Børge G Nordestgaard, Ulf Landmesser, Sotirios Tsimikas, A Michael Lincoff

Am Heart J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "Weight-loss drugs like Wegovy could lead to an increased risk of fragility fractures in population at risk".
Robert F Kushner, Donna H Ryan, Nina M Harder-Lauridsen, Ole Kleist Jeppesen, Klaus Kallenbach, A Michael Lincoff

Obesity (Silver Spring)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing Obesity.
Christos P Kotanidis, A Michael Lincoff, Scott A Shikora

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.
Stephen J Nicholls, Kausik K Ray, A Michael Lincoff, Evelyn Sarnes, Kristin K Gillard

Am J Cardiovasc Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: A meta-analysis of eleven cardiovascular outcome trials.
Yu Mi Kang, Erin A Bohula, A Michael Lincoff, Donna H Ryan, KyungAh Im

Diabetes Obes Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Stent Infection in Acute Double Valve Endocarditis.
Filip Stembal, Maria Bakaeen, Valentina Lara Erazo, A Michael Lincoff, Steven M Gordon

JACC Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes.
Christopher Lübker, Jigish Bhavsar, Ruben Duque do Vale, Scott S Emerson, Emil Nørtoft, A Michael Lincoff

Adv Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial.
Ulrich Laufs, A Michael Lincoff, Stephen J Nicholls, Na Li, LeAnne Bloedon

J Clin Lipidol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.
Robert F Kushner, Donna H Ryan, John Deanfield, Alexander Kokkinos, Cintia Cercato, A Michael Lincoff

Obesity (Silver Spring)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity.
Subodh Verma, Scott Emerson, Jorge Plutzky, Steven E Kahn, Signe Stensen, A Michael Lincoff

J Am Coll Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone Replacement Therapy and Risk of COVID-19 and Effect of COVID-19 on Testosterone's Treatment Effect.
Karol M Pencina, A Michael Lincoff, Eric A Klein, Steven E Nissen, Yili Valentine Shang

J Endocr Soc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis.
Harold E Bays, LeAnne Bloedon, Danielle Brennan, Lei Lei, A Michael Lincoff

J Am Heart Assoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.
C Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, Gerald Chi, Harvey White, A Michael Lincoff

Eur Heart J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
C Michael Gibson, Gerald Chi, Danielle Duffy, M Cecilia Bahit, Harvey White, A Michael Lincoff

J Am Coll Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
Mikhail N Kosiborod, John Deanfield, Richard Pratley, Barry A Borlaug, Javed Butler, A Michael Lincoff

Lancet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis